Abiopharma

🔍 Brodie Bradley Harris (Executive)

Company: Douglas Elliman Inc. (DOUG)

Report Date: 2026-08-13

Detailed Transactions and Holdings:

• Sold 24,593 shares of Common Stock at $2.0075 per share (Direct)
  Date: 2026-08-13 | Code: F | equity_swap_involved: 0 | shares_owned_after: 400,407.00 | transaction_form_type: 4 | Footnotes: F1, F1

Footnotes:

• F1: Represents withholdings of shares as payment of the Reporting Person's payroll tax liabilities incident to the vesting of an aggregate of 62,500 shares of restricted stock, which were awarded to Reporting Person on August 13, 2025. The shares withheld were valued at $2.0075 per share, which represented the average of the low ($1.95) and high ($2.065) stock prices of the Issuer's Common Stock on August 13, 2026, the date of vesting.